Specificity of CD8 cells in islets from type 1 diabetes patients

1 型糖尿病患者胰岛中 CD8 细胞的特异性

基本信息

项目摘要

DESCRIPTION (provided by applicant): Human type 1 diabetes (T1D) is characterized by the specific immune-mediated destruction of insulin- producing pancreatic beta cells. Importantly, earlier studies demonstrated that immune memory to beta cell antigens plays a significant role in their destruction, which constitutes a major obstacle for long-term acceptance of islet cell grafts (1-3). There is now consensus that CD8 T cells constitute the principal T cell type in insulitis in recent-onset patients (4). Such CD8 T cells are potentially very harmful, since they have been shown to readily kill human beta cells in vivo, if enough MHC class I is upregulated on their surface (5). However, not much is known about the overall CD8 specificities and frequencies present in islets and the cause for their entry and activation. Possible targets are known autoantigens derived from beta cells such as insulin, IGRP, IA-2 and GAD (see Table 1 for abbreviations) and cellular matrix proteins, which could become presented when beta cells are destroyed but also viral proteins for example enteroviral determinants. The overall objective of this proposal is therefore to reveal the specificity of CD8 T lymphocytes that are found in human islets and address whether viral infections may play a role in this scenario. [In parallel studies, we aim to confirm our preliminary data showing that islet infiltration may persist long beyond clinical diagnosis and in such cases follows a continuous course both quantitatively and qualitatively. The latter finding would have broad implications on the feasibility of experimental tolerization therapies in longstanding patients.] Our first goal is to systematically detect autoreactive CD8 T cells within human islets and correlate their numbers and activation status with the local histopathology of the islet. In situ tetramer staining of freshly frozen human pancreata and pancreatic lymph nodes now available through the unique nPOD organ repository will be used. In addition, humanized HLA A2 expressing transgenic mice will be utilized to map responses to novel cellular matrix (self) epitopes which will then be validated on human tissues. Our second goal is to search for [CVB]-specific T cells within islets and address the important question, whether viral infection makes islets more accessible for autoreactive T cell or vice versa. To this purpose human sections from pancreata of diabetic patients will be probed with [CVB-specific] tetramers and viral nucleic acids will be detected in collaboration with Heikki Hyoty and Stephen Tracy. In addition, diabetes- prone HLA-A2 humanized mice and fluorescently labeled Coxsackie B virus strains will be used to address the fundamental 'chicken-egg' question, whether viral infections are more important to condition islets for autoreactive lymphocyte entry and destruction, or, conversely, whether autoreactive attacks make islets more accessible for enteroviral infections. PUBLIC HEALTH RELEVANCE: We wish to systematically investigate the specificity of the immune cells that destroy insulin-producing beta cells in pancreas tissue obtained from patients with type 1 diabetes. Additionally, we will evaluate the potential role of enteroviruses in type 1 diabetes development in both patients and mouse models. This research will expand our knowledge on how the disease is triggered in susceptible individuals and on how we may therapeutically target these cells in order to restore tolerance.
描述(由申请人提供):人1型糖尿病(T1 D)的特征在于特异性免疫介导的胰岛素产生胰腺β细胞的破坏。重要的是,早期的研究表明,对β细胞抗原的免疫记忆在其破坏中起着重要作用,这构成了胰岛细胞移植物长期接受的主要障碍(1-3)。目前的共识是CD 8 T细胞构成了近期发病患者胰岛炎的主要T细胞类型(4)。这样的CD 8 T细胞是潜在地非常有害的,因为它们已经显示出在体内容易杀死人β细胞,如果足够的MHC I类在它们的表面上被上调(5)。然而,对胰岛中存在的总体CD 8特异性和频率以及它们进入和激活的原因知之甚少。可能的靶标是已知的来源于β细胞的自身抗原,例如胰岛素、HRP、IA-2和GAD(缩写见表1)和细胞基质蛋白,当β细胞被破坏时,细胞基质蛋白可以被呈递,但也有病毒蛋白,例如肠道病毒决定簇。因此,该提案的总体目标是揭示在人类胰岛中发现的CD 8 T淋巴细胞的特异性,并解决病毒感染是否可能在这种情况下发挥作用。[In通过平行研究,我们的目的是证实我们的初步数据,这些数据表明胰岛浸润可能持续很长时间超过临床诊断,并且在这种情况下,在定量和定性方面都遵循连续的过程。后一项发现将对长期患者的实验性耐受化疗法的可行性产生广泛影响。我们的第一个目标是系统地检测人类胰岛内的自身反应性CD 8 T细胞,并将其数量和激活状态与胰岛的局部组织病理学相关联。将使用目前可通过独特的nPOD器官库获得的新鲜冷冻人胰腺和胰腺淋巴结的原位四聚体染色。此外,表达人源化HLA A2的转基因小鼠将用于绘制对新的细胞基质(自身)表位的应答,然后在人组织上验证。我们的第二个目标是在胰岛内寻找CVB特异性T细胞,并解决重要的问题,即病毒感染是否使胰岛更容易获得自身反应性T细胞,反之亦然。为此,将用[CVB特异性]四聚体探测糖尿病患者胰腺的人类切片,并与Heikki Hyoty和Stephen Tracy合作检测病毒核酸。此外,糖尿病易感的HLA-A2人源化小鼠和荧光标记的科萨基B病毒株将用于解决基本的“鸡-蛋”问题,即病毒感染是否对调节胰岛的自身反应性淋巴细胞进入和破坏更重要,或者相反,自身反应性攻击是否使胰岛更容易受到肠道病毒感染。 公共卫生关系:我们希望系统地研究免疫细胞的特异性,这些免疫细胞破坏从1型糖尿病患者获得的胰腺组织中产生胰岛素的β细胞。此外,我们将评估肠道病毒在患者和小鼠模型中1型糖尿病发展中的潜在作用。这项研究将扩大我们对易感个体如何触发疾病以及我们如何治疗靶向这些细胞以恢复耐受性的知识。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Matthias G. Von Herrath其他文献

Matthias G. Von Herrath的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Matthias G. Von Herrath', 18)}}的其他基金

Treg stability in viral infection and autoimmunity
病毒感染和自身免疫中 Treg 的稳定性
  • 批准号:
    8495227
  • 财政年份:
    2013
  • 资助金额:
    $ 40.14万
  • 项目类别:
Treg stability in viral infection and autoimmunity
病毒感染和自身免疫中 Treg 的稳定性
  • 批准号:
    8377922
  • 财政年份:
    2012
  • 资助金额:
    $ 40.14万
  • 项目类别:
Specificity of CD8 cells in islets from type 1 diabetes patients
1 型糖尿病患者胰岛中 CD8 细胞的特异性
  • 批准号:
    8655830
  • 财政年份:
    2011
  • 资助金额:
    $ 40.14万
  • 项目类别:
Specificity of CD8 cells in islets from type 1 diabetes patients
1 型糖尿病患者胰岛中 CD8 细胞的特异性
  • 批准号:
    8195256
  • 财政年份:
    2011
  • 资助金额:
    $ 40.14万
  • 项目类别:
Specificity, Phenotype and Function of Pancreatic CD8 T Cells in Human Type 1 Diabetes
人类 1 型糖尿病中胰腺 CD8 T 细胞的特异性、表型和功能
  • 批准号:
    9238399
  • 财政年份:
    2011
  • 资助金额:
    $ 40.14万
  • 项目类别:
Specificity of CD8 cells in islets from type 1 diabetes patients
1 型糖尿病患者胰岛中 CD8 细胞的特异性
  • 批准号:
    8451478
  • 财政年份:
    2011
  • 资助金额:
    $ 40.14万
  • 项目类别:
Specificity of CD8 cells in islets from type 1 diabetes patients
1 型糖尿病患者胰岛中 CD8 细胞的特异性
  • 批准号:
    8828063
  • 财政年份:
    2011
  • 资助金额:
    $ 40.14万
  • 项目类别:
Specificity, Phenotype and Function of Pancreatic CD8 T Cells in Human Type 1 Diabetes
人类 1 型糖尿病中胰腺 CD8 T 细胞的特异性、表型和功能
  • 批准号:
    10061526
  • 财政年份:
    2011
  • 资助金额:
    $ 40.14万
  • 项目类别:
Treg stability in viral infection and autoimmunity
病毒感染和自身免疫中 Treg 的稳定性
  • 批准号:
    8006796
  • 财政年份:
    2010
  • 资助金额:
    $ 40.14万
  • 项目类别:
How IL-10R blockade can resolve persistent viral infections
IL-10R 阻断如何解决持续性病毒感染
  • 批准号:
    7919813
  • 财政年份:
    2009
  • 资助金额:
    $ 40.14万
  • 项目类别:

相似海外基金

Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 40.14万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
  • 批准号:
    10100360
  • 财政年份:
    2024
  • 资助金额:
    $ 40.14万
  • 项目类别:
    Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
  • 批准号:
    24K04974
  • 财政年份:
    2024
  • 资助金额:
    $ 40.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
  • 批准号:
    2312319
  • 财政年份:
    2023
  • 资助金额:
    $ 40.14万
  • 项目类别:
    Standard Grant
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
  • 批准号:
    23K01686
  • 财政年份:
    2023
  • 资助金额:
    $ 40.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
  • 批准号:
    23K01692
  • 财政年份:
    2023
  • 资助金额:
    $ 40.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
  • 批准号:
    23K01695
  • 财政年份:
    2023
  • 资助金额:
    $ 40.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
  • 批准号:
    23K01713
  • 财政年份:
    2023
  • 资助金额:
    $ 40.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
  • 批准号:
    23K01715
  • 财政年份:
    2023
  • 资助金额:
    $ 40.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
  • 批准号:
    10585388
  • 财政年份:
    2023
  • 资助金额:
    $ 40.14万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了